Home / India News / Top headlines: HCL Tech Q2 profit rises, Remdesivir falls flat in WHO study

Top headlines: HCL Tech Q2 profit rises, Remdesivir falls flat in WHO study

Business Standard brings you the top headlines of the day

HCl Tech Q2 net income rises 4.4% to Rs 2,651 crore, EBIT up 17.9%

Premium

Dollar revenues stood at $2,507 million, a 4.5 per cent rise in constant currency terms over the previous quarter.

BS Web Team New Delhi

3 min read Last Updated : Oct 16 2020 | 5:45 PM IST

JK Tyre, other companies face antitrust scrutiny in bid-rigging case

India's antitrust regulator is investigating JK Tyre & Industries Ltd after a state government accused the company of bid rigging, and the probe has been expanded to other firms, according to sources and legal filings seen by Reuters. The Competition Commission of India (CCI) last year ordered a probe after the northern state of Haryana said JK Tyre employed unfair trade practices while bidding to supply tyres for public transport vehicles, a court filing showed. Read More...

HCL Tech Q2 profit rises 18.5% to Rs 3,142 crore, outperforms projections

Topics : Hydroxychloroquine HCL Technologies Q2 results World Health Organization Tata Motors Moody's

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in